IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

BVF Inc

Q3 2014 Holdings

Filed 2014-11-14 | 32 holdings | $12.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Ardelyx Inc(ARDX)COM039697107$6.4M453,54152.4%
Cytokinetics Inc(CYTK)COM NEW23282W605$5.4M1,527,00043.7%
Ironwood Pharmaceuticals Inc(IRWD)COM CL A46333X108$72.5K5,597,0650.6%
Receptos IncCOM756207106$71.2K1,146,3000.6%
Ligand Pharmaceuticals Inc(LGND)COM NEW53220K504$52.1K1,108,7630.4%
Array Biopharma Inc(ARRYEUR)COM04269X105$49.5K13,876,5130.4%
Chemocentryx Inc(CCXIEUR)COM16383L106$38.7K8,596,7720.3%
Oncomed Pharmaceuticals IncCOM68234X102$24.4K1,287,8470.2%
Oncothyreon IncCOM682324108$18.9K9,867,2780.2%
Five Prime Therapeutics Inc(FPRX)COM33830X104$17.1K1,461,9000.1%
Targacept IncCOM87611R306$16.8K6,655,1280.1%
Loxo Oncology IncCOM548862101$15.7K1,192,2020.1%
Concert Pharmaceuticals Inc(CNCEEUR)COM206022105$15.2K1,206,4590.1%
Array Biopharma IncNOTE 3.000% 6/004269XAA3$14.4K$16,000,0000.1%
Exelixis IncNOTE 4.250% 8/130161QAC8$10.0K$17,175,0000.1%
QLT IncCOM746927102$9.5K2,093,5630.1%
Proqr Thrapeutics N VSHS EURON71542109$9.4K549,0000.1%
Trevena IncCOM89532E109$7.2K1,118,7430.1%
Vitae Pharmaceuticals IncCOM92847N103$5.1K666,0000.0%
Arqule Inc(ARQLUSD)COM04269E107$4.8K4,300,8870.0%
Regado Biosciences IncCOM75874Q107$2.9K2,607,0910.0%
Biolinerx LTDSPONSORED ADR09071M106$2.3K1,501,0000.0%
Kalobios Pharmaceuticals IncCOM48344T100$1.8K1,162,0000.0%
Oncogenex Pharmaceuticals inCOM68230A106$1.8K662,0690.0%
Sophiris BIO IncCOM NEW83578Q209$1.8K600,0000.0%
Regulus Therapeutics IncCOM75915K101$1.3K184,9990.0%
Achaogen IncCOM004449104$1.2K136,6000.0%
Biota Pharmaceutials IncCOM090694100$1.1K435,9000.0%
Anthera Pharmaceuticals IncCOM NEW03674U201$1.1K559,6240.0%
Uniqure NV(QURE)SHSN90064101$981106,5000.0%
Palatin Technologies IncCOM PAR $ .01696077403$698750,6550.0%
Transcept Pharmaceuticals inCOM89354M106$304150,0000.0%